Avasimibe, an inhibitor of cholesterol esterification enzyme, significantly empowers the anti-tumor response of CD8+ T cells, and its combination with anti-PD-1 antibody has a better efficacy in melanoma [13]. This evidence concerns the gene CD8A and neoplasm.